Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

Acne drugs refer to the medications used for treating a dermatological infection characterized by the inflammation in the hair follicles on skin. It is usually caused by hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate intake of water and excessive consumption of sugars, salts or carbohydrates. Some of the commonly used acne drugs include topical medications, such as retinoids, salicylic and azelaic acid-based ointments and dapsone-based gels, along with antibiotics, anti-androgen agents and isotretinoin. These drugs minimize the levels of oil production in the body, speed up skin cell turnover, control acne breakouts, reduce scarring and damage to the skin and prevent inflammation.

The increasing prevalence of skin-related diseases, such as acne vulgaris, is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the benefits of using premium skin care products is driving the market growth. The market is further being driven by the development of effective therapeutics and treatment alternatives with reduced side effects and high potential. Increasing consumer preference for products manufactured using natural ingredients is acting as another growth-inducing factor. Manufacturers are, therefore, developing products infused with natural herbs and organic ingredients, such as aloe vera, green tea, honey, jojoba oil and rosemary, for treating acne. Other factors, including rising expenditure capacities of consumers, along with the proliferation of online retail platforms that offer customized acne drugs according to the user’s skin type, are expected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global acne drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on acne type, drug class, drug type and route of administration.

Breakup by Acne Type:

Comedonal
Inflammatory
Cystic
Postsurgical/Wound


Breakup by Drug Class:

Retinoids
Antibiotics
Hormonal Agents
Combination Drugs
Others


Breakup by Drug Type:

OTC Drugs
Prescription Drugs


Breakup by Route of Administration:

Topical
Oral
Injectable


Breakup by Region:

North America

United States
Canada


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, Cipher Pharmaceuticals Inc., Galderma Holding SA, Johnson & Johnson, Pfizer Inc., Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

How has the global acne drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global acne drugs market?
What are the key regional markets?
What is the breakup of the market based on the acne type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global acne drugs market and who are the key players?
What is the degree of competition in the industry?